Who invested in Memo Therapeutics?
4 investors are on record as having backed Memo Therapeutics — Developing antibodies to treat viral infections and cancer, in Biotech, Switzerland. Each row below says whether the round came from the investor's own portfolio page or from the press.
memo-therapeutics.comMemo Therapeutics investors
Kurma PartnersFunds healthcare and biotech companies from creation to expansion, building ventures from…series-c$20MMay 2024
Ysios CapitalInvests in highly innovative biotech developing novel therapies for high unmet medical…series-c$45MMay 2024press
2 more investors on record for Memo Therapeutics.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed Memo Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.